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Abstract
Objective To investigate whether the mortality gap has reduced in recent
years between people with schizophrenia or bipolar disorder and the
general population.
Design Record linkage study.
Setting English hospital episode statistics and death registration data
for patients discharged 1999-2006.
Participants People discharged from inpatient care with a diagnosis of
schizophrenia or bipolar disorder, followed for a year after discharge.
Main outcome measures Age standardised mortality ratios at each
time, comparing the mortality in people with schizophrenia or bipolar
disorder with mortality in the general population. Poisson test of trend
was used to investigate trend in ratios over time.
Results By 2006 standardised mortality ratios in the psychiatric cohorts
were about double the population average. The mortality gap widened
over time. For people discharged with schizophrenia, the ratio was 1.6
(95% confidence interval 1.5 to 1.8) in 1999 and 2.2 (2.0 to 2.4) in 2006
(P<0.001 for trend). For bipolar disorder, the ratios were 1.3 (1.1 to 1.6)
in 1999 and 1.9 (1.6 to 2.2) in 2006 (P=0.06 for trend). Ratios were
higher for unnatural than for natural causes. About three quarters of all
deaths, however, were certified as natural, and increases in ratios for
natural causes, especially circulatory disease and respiratory diseases,
were the main components of the increase in all cause mortality.
Conclusions The total burden of premature deaths from natural causes
in people with schizophrenia or bipolar disorder is substantial. There is
a need for better understanding of the reasons for the persistent and
increasing gap in mortality between discharged psychiatric patients and
the general population, and for continued action to target risk factors for
both natural and unnatural causes of death in people with serious mental
illness.
Introduction
Schizophrenia has been described as a life shortening condition,1
and many studies have shown that people with schizophrenia
or bipolar disorder have higher mortality rates than the general
population, both as a result of natural2-10 and unnatural causes,2-6
including suicide. Over the past decade several strategies have
been implemented in England andWales aimed at reducing the
mortality gap between people with serious mental illness and
the general population, including those to address deliberate
self harm and to reduce suicide,7-9 to decrease smoking,10-12
alcoholism, and drug misuse,13 14 and to deal with other lifestyles
associated with increased mortality.15 16 Recent studies have
suggested that the rate of suicide has been stabilising among
people with mental disorders as a whole17-21; however, trends in
mortality for people with schizophrenia or bipolar disorder
remain poorly characterised, particularly the relative
contributions of natural and unnatural causes. The United
Kingdom government’s recent mental health strategy states that
“more people with mental health problems will have good
physical health” as one of its objectives, specifically stating that
“fewer people with mental health problems will die
prematurely.”22 It is therefore timely to review the level of and
trends in these recognised inequalities.
We investigated trends in mortality between 1999 and 2006
during the year after discharge from hospital for people with
schizophrenia or bipolar disorder as the principal diagnosis at
discharge. We compared mortality in these populations with
mortality in the general population of equivalent age in England
to determine whether the “mortality gap” between people with
these mental disorders and the general population has narrowed
in recent years and to describe the relative contributions from
natural and unnatural causes of death.
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Method
Data sources and population included in this
study
Our data for analysis came from a linked dataset of English
national hospital episode statistics and data from death
certification built by the team that developed and manages the
Oxford record linkage study. The hospital episode statistics
component of the dataset includes statistical abstracts of records
of all inpatient episodes undertaken in National Health Service
(NHS) trusts in England, including acute hospitals and mental
health trusts. Information about deaths came from death
certificates held by the Office for National Statistics. This
information included the date of death and the causes of death,
which were coded by the Office for National Statistics using
the ninth and 10th revisions of the international classification
of diseases (ICD-9 and ICD-10).
We extracted all records of discharges from inpatient care in
England from 1 January 1999 to 31 December 2006 with either
schizophrenia (ICD-10 codes F20-29) or bipolar affective
disorder (ICD-10 code F31) as the principal diagnosis on the
discharge record.
Our primary outcome was mortality within 365 days after
psychiatric inpatient care as defined above.We also investigated
deaths from unnatural and natural causes. Unnatural deaths were
defined on the basis of ICD-10 codes V01-Y98 or ICD-9 codes
E800-999 recorded anywhere on the death certificate; the
remaining deaths were classified as natural. To allow more
detailed interpretation of deaths under these broad categories
we have also presented data for deaths from the following
specific causes where there were sufficient deaths to provide a
stable estimate of risk of mortality—namely, deaths from
cardiovascular disease (ICD-10 codes I00-99, ICD-9 codes
390-459), respiratory disease (ICD-10 codes J00-99, ICD-9
codes 460-519), cancer (ICD-10 codes C00-D48, ICD-9 codes
140-239), accidents (ICD-10 codes V01-X59, ICD-9 codes
E800-929), and suicide/deaths from undetermined intent
(ICD-10 codes X60-89 and Y10-34, ICD-9 codes E950-959
and E980-989).
Analysis
We calculated mortality after hospital discharge as age and sex
standardised mortality ratios, comparing mortality in people
with schizophrenia or bipolar disorder with mortality in the
general population of England. Standardisation was done by
using the indirect method, in five year age groups, with the age
and sex specific mortality rates of England in the same time
periods as the standard. These age and sex specific rates were
applied to the age and sex structure of each of the discharge
cohorts with schizophrenia or bipolar disorder to calculate an
“expected” number of deaths. The observed number was
comparedwith the expected number to calculate the standardised
mortality ratios. Its confidence intervals were calculated as
described elsewhere.23 We further compared the mortality rates
in three broad age groups: <45, 45-64, and 65-84 (with age
standardisation, as above, using five year age groups within
each truncated broader age group). We excluded analysis of
those aged over 85 because of small numbers.
We used the Poisson test of trend to investigate whether there
was a significant trend in standardised mortality ratios over
time.24
Results
Trends in discharges with schizophrenia and
bipolar disorder
For this study we included 100 851 discharges from hospital
for bipolar disorder and 272 248 discharges for schizophrenia
in England for 1999-2006. Tables 1⇓ and 2⇓ show the basic
demographic characteristics of the populations. Over the course
of the study, the total number of discharges for bipolar disorder
decreased by 3.9% from 12 369 to 11 888 (table 1) and the total
number of discharges for schizophrenia decreased by 10.9%
from 35 348 to 31 486 (table 2). About three in four of the deaths
in each of the two cohorts were from natural causes.
Standardised mortality ratios for
schizophrenia and bipolar disorder
Age and sex standardised mortality ratios in the psychiatric
cohorts were about double the population average. For example,
in the 2006 cohort the ratio was 2.2 in the population discharged
with schizophrenia and 1.9 in the population discharged with
bipolar disorder. Standardised mortality ratios were higher in
younger than in older people: in those aged under 45 discharged
in 2006, the ratios were 6.2 (95% confidence interval 4.9 to 7.5)
for schizophrenia and 3.4 (1.7 to 5.1) for bipolar disorder
compared with 2.0 (1.7 to 2.3) and 1.8 (1.4 to 2.2), respectively,
in people aged 65-84 (tables 3⇓ and 4⇓). Men with a discharge
diagnosis of schizophrenia had a significantly higher risk of
death within the first year than women. For example, in the
2006 cohort the standardised mortality ratio for men was 3.2
(2.8 to 3.6) and 1.8 (1.5 to 2.1) for women (table 4⇓). There
was no significant sex difference in mortality risk for those
discharged with a diagnosis of bipolar disorder (table 3⇓).
Trends in mortality ratios
As shown in table 4⇓ and figure 1⇓, standardisedmortality ratios
for people with schizophrenia increased from 1.6 (1.5 to 1.8)
in people discharged in 1999 to 2.2 (2.0 to 2.4) in people
discharged in 2006. The Poisson test for trend confirmed that
the trend in risk of mortality was significant (P<0.001). For
people with bipolar disorder, standardised mortality ratios
increased from 1.3 (1.1 to 1.6) in people discharged in 1999 to
1.9 (1.6 to 2.2) in people discharged in 2006 (table 3⇓). The
Poisson test of trend had results of borderline significance
(P=0.06). Figures 2 and 3⇓⇓ summarise the data for the people
with bipolar disorder or schizophrenia and the general population
expressed as rates (to give absolute values). While the mortality
rates in the general population tended to decline over time, those
in the populations with mental disorders did not. Compared
with the mortality rate for the general population, the mortality
gap remained fairly stable for adults aged under 65; for those
aged 65-84, however, the mortality gap widened during the
study period.
Standardised mortality ratios for
unnatural/natural causes and specific causes
For unnatural causes, the standardised mortality ratios showed
no evidence of a narrowing mortality gap. In people with
schizophrenia they were 11.6 (9.5 to 13.7) in the 1999 cohort
and 11.6 (9.3 to 13.9) in the 2006 cohort. The corresponding
figures for bipolar disorder were 9.3 (6.0 to 12.7) and 12.6 (8.6
to 16.6). Numbers in individual age groups were small, but there
was no evidence of a narrowing of the gap in any age group
(table 5⇓).
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For natural causes, the mortality gap widened (table 6⇓). For
people with schizophrenia, the standardised mortality ratio was
1.2 (1.1 to 1.4) in the 1999 cohort and 1.7 (1.5 to 1.9) in the
2006 cohort. The corresponding figures for bipolar disorder
were 1.1 (0.9 to 1.3) and 1.4 (1.2 to 1.7). Table 7⇓ shows that
deaths from cardiovascular disease and respiratory diseases
accounted for most of this increase. From 1999 to 2006, in those
with schizophrenia, the standardised mortality ratios for
circulatory disease rose from 1.6 (1.4 to 1.9) to 2.5 (2.1 to 2.9),
while the risk of death from respiratory disease increased from
3.1 (2.6 to 3.6) to 4.7 (3.8 to 5.6). The figures for those
discharged with bipolar disorder rose from 1.6 (1.2 to 2.0) to
2.5 (1.9 to 3.1) for circulatory disease and from 3.0 (2.1 to 3.8)
to 5.8 (4.3 to 7.3) for respiratory disease.
Discussion
Principal findings
The risk of death for people recently discharged from inpatient
psychiatric care in England is significantly higher than that in
the general population. This excess risk was observed for
patients with a diagnosis of schizophrenia and for those with a
diagnosis of bipolar disorder. Our findings of a persistent
mortality gap in England in patients discharged between 1999
and 2006 are similar to results recently published by Tiihonen
et al on all cause mortality in people with schizophrenia over a
similar time period in Finland.25 26 Additionally, our findings
suggest that the differential mortality for people with
schizophrenia has widened in some groups, a result that is
similar to the findings from a systematic review by Saha et al
in 2007.27 Much of the increase in mortality is attributable to
deaths from natural causes, especially circulatory disease and
respiratory disease. Our findings support the recommendation
of Saha et al that “in light of the potential for second-generation
antipsychotic medications to further adversely influence
mortality rates . . . optimizing the general health of people with
schizophrenia warrants urgent attention.”27
Strengths and weaknesses
Strengths of this study include its large size and the fact that it
includes all records of discharges with a diagnosis of
schizophrenia or bipolar disorder in the study period and is
therefore nationally representative. By linkage to national
mortality data we have included comprehensive information on
mortality in these vulnerable groups, especially in the period
after discharge from hospital when the risk of death is greatest.2
In addition, to the best of our knowledge, ours are the first
published findings on trends in mortality over the past decade
for people with bipolar disorder in England, a condition that
shares some clinical and management characteristics with
schizophrenia.28 These study characteristics aid the
generalisability of our findings compared with previous studies
in the UK, which have been limited to case registers within
individual mental health trusts.29 30
To quantify the mortality gap and assess the trend in risk of
mortality for people with schizophrenia or bipolar disorder, we
calculated standardised mortality ratios, which take into account
differences in the age structure of the cases, as well as changes
in the underlying mortality rates of the general population. The
widening gap in standardised mortality ratios alone could
represent an absolute rise in mortality in the psychiatric
population or a fall in mortality in the general population in
conjunction with a smaller fall in mortality in the psychiatric
population. Accordingly, we have presented rates for all causes
of death after discharge compared with national mortality rates
over the same period, which allowed us to compare trends in
the absolute difference in mortality risk between the groups.
Both figures—the standardised mortality ratios and the
rates—show that the risk of mortality after discharge is
substantial and that the gap in risk, whether calculated in relative
or absolute terms, remains substantial. The standardised
mortality ratios for schizophrenia and bipolar disorder towards
the end of this observation period are similar to those recently
reported from the South London and Maudsley Biomedical
Research Centre psychiatric case register for 2007-9, which also
found a similarly pronounced excess in younger patients.29
Potential limitations include the usual caveats concerning the
use of routinely collected data, including information from
hospital records and death certificates, which are not collected
for research purposes.31-34 There are also caveats about the
validity of a dichotomy between “natural” and “unnatural”
categories of death, although the definitions of these categories
from the ICD codes were standard.35 36The case groups consisted
of people who had been recently admitted to hospital with a
principal diagnosis of a mental disorder during the period in
question and cannot be said to represent all people with the
disorders; they are likely to represent a more severely affected
group at a period of higher risk. The severity of the disorders
in the case groups might have changed over the monitoring
period because of changes in admission policy. Keown et al
found little evidence of any significant decrease in admissions
for schizophrenia or bipolar disorder during this period,37 and
our finding of minor reductions in discharges over the
observation period compared with the increases in standardised
mortality ratios suggests that the concentration of mortality risk
in these patients admitted to hospital is unlikely to be the sole
explanation for the widening mortality gap, although residual
confounding with severity of illness cannot be excluded entirely.
Interpretation, unanswered questions, and
need for further work
Schizophrenia and bipolar disorder are known to be associated
with a higher risk of mortality.1 Over the past decade the
contribution of natural causes to excess mortality in people with
severe mental illness has been increasingly recognised,
particularly the impact of coronary heart disease, stroke, and
cancer.38 For example, Osborn and colleagues used information
from the UK General Practice Research Database to follow up
a community sample of people with severe mental illness and
found that these people had a significantly increased risk of
death from coronary heart disease and stroke compared with
controls that was not wholly explained by antipsychotic
medication, smoking, or social deprivation.39
While knowledge about the specific causes of death in severe
mental illness are becoming clearer, the pathogenic mechanisms
that culminate in higher than expected mortality from natural
causes in people with mental disorder are little understood and
likely to be complex.40 41 Mechanisms acting through the direct
effects of symptoms of mental disorder are unlikely to have a
large effect on mortality from natural causes, although they are
likely to influence death from suicide and other unnatural
causes.42 Premature deaths from natural causes are likely to be
influenced by adverse lifestyle and social factors associated
with the presence of mental illness—such as smoking, use of
alcohol and illicit drugs, and exposure to poor housing and social
conditions40 43—or the adverse effects of antipsychotic
medication.44 45 It has been suggested, however, that these factors
do not account for all the excess mortality,39 and there is an
urgent need for more research to understand the contribution of
the six leading global risk factors for mortality identified by
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WHO—namely, hypertension, smoking, raised glucose
concentration, physical inactivity, overweight and obesity, and
high cholesterol concentration—to excess mortality in people
with severe mental illness, including schizophrenia and bipolar
disorder.41
Our results reinforce the need for further research in the UK as
the mortality gap has not decreased and is increasing in some
groups, such as those aged over 65. These results have particular
policy relevance in the context of the implementation of the
new national mental health strategy in England. They strongly
point to the need for continued action to target risk factors for
both natural and unnatural causes of death, including known
risk factors for circulatory and respiratory disease, particularly
to lower the risk for these people in the year after discharge
from hospital. It is encouraging that the government has
recognised and prioritised the importance of preventing
premature mortality in its recently published mental health
strategy.22 A reduction of the gap is also a challenge for the
forthcoming reorganisation of the NHS in England, for general
practitioner commissioning, and for the reorganisation’s
emphasis on an NHS driven by outcomes. The already widening
mortality gap between people with schizophrenia or bipolar
disorder and the general population, however, suggests that
these policies might be challenging aspirations.
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What is already known on this topic
People with schizophrenia or bipolar disorder have higher mortality rates than the general population, both as a result
of natural and unnatural causes
Recent evidence suggests that the rate of suicide and death from unnatural causes has been stabilising among people
with mental illness in the UK
The English government’s recent mental health strategy has stated clearly that “fewer people with mental health
problems will die prematurely”
What this study adds
The mortality gap between people with schizophrenia or bipolar disorder who have been recently discharged from
hospital and the general population persisted between 1999 and 2006 in England
For some age groups, such as those aged 65-84, the mortality gap has increased
Most of this excess mortality was the result of deaths from natural causes, especially deaths from circulatory and
respiratory diseases
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Tables
Table 1| Characteristics of people discharged with principal diagnosis of bipolar disorder (ICD-10 code F31) in England, 1999-2006
Deaths within 365 days
Median age
(men/women)% male
No of people
dischargedNo of dischargesYear of discharge
From unnatural causes (% of all
deaths)From all causes
30 (22.7)13242/4838931212 3691999
35 (26.5)13242/4838921712 2852000
40 (27.9)14343/4838938412 8032001
38 (23.6)16143/4839961213 1532002
46 (26.3)17544/4839972312 7572003
51 (32.3)15843/484010 10213 2212004
43 (27.6)15644/4839928412 3752005
38 (25.7)14844/4841908611 8882006
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Table 2| Characteristics of people discharged with principal diagnosis of schizophrenia (ICD-10, codes F20-29) in England, 1999-2006
Deaths within 365 days
Median age
(male/female)% male
No of people
dischargedNo of dischargesYear of discharge
From unnatural causes (% of all
deaths)From all causes
114 (27.4)41634/445827 13335 3481999
113 (26.5)42734/445825 78533 7932000
111 (27.2)40835/445925 87034 4782001
86 (22.1)38935/446025 52434 1052002
106 (23.1)45935/446025 85633 6652003
123 (28.7)42935/446027 42535 5402004
112 (27.1)41436/446025 70933 8332005
96 (25.5)37636/446124 20531 4862006
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Table 3| Age and sex standardised all causemortality ratios in year after hospital discharge between 1999 and 2006 with principal diagnosis
of bipolar disorder (ICD-, 10, code F31) by age
65-84 years45-64 years<45 yearsAll agesYear of discharge
Men and women
1.11.74.01.31999
1.32.33.91.42000
1.32.25.21.52001
1.62.74.61.72002
1.62.65.41.82003
1.42.78.01.82004
1.72.64.41.82005
1.82.63.41.92006
Men
1.31.85.81.71999
1.62.13.71.82000
1.52.65.11.92001
1.62.56.32.12002
1.62.95.12.12003
1.72.68.62.32004
1.92.44.72.02005
2.02.35.12.32006
Women
1.22.02.31.41999
1.22.94.81.52000
1.42.15.31.62001
1.83.22.81.82002
1.82.66.11.92003
1.33.07.91.62004
1.73.04.41.92005
1.93.11.51.82006
No commercial reuse: See rights and reprints http://www.bmj.com/permissions Subscribe: http://www.bmj.com/subscribe
BMJ 2011;343:d5422 doi: 10.1136/bmj.d5422 Page 8 of 13
RESEARCH
Table 4| Age and sex standardised all causemortality ratios in year after hospital discharge between 1999 and 2006 with principal diagnosis
of schizophrenia (ICD-10, codes F20-29) by age
65-84 years45-64 years<45 yearsAll agesYear of discharge
Men and women
1.33.46.91.61999
1.73.57.51.92000
1.73.46.51.72001
1.63.36.21.82002
2.04.36.72.22003
1.83.67.52.12004
1.93.59.12.32005
2.03.96.22.22006
Men
1.33.06.12.31999
1.83.26.82.62000
1.63.45.82.52001
1.63.55.52.52002
2.04.26.22.92003
2.04.16.483.02004
2.33.28.73.32005
2.24.06.13.22006
Women
1.44.27.31.61999
1.84.28.21.92000
1.93.56.41.72001
1.73.06.11.72002
2.14.45.82.02003
1.82.97.91.82004
1.73.96.61.92005
2.13.64.11.82006
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Table 5| Age and sex standardised mortality ratios for unnatural causes of death in year after hospital discharge between 1999 and 2006
by age and principal diagnosis
65-84 years45-64 years<45 yearsAll agesYear of discharge
Bipolar disorder (ICD-10, code F31)
6.510.610.69.31999
9.517.69.411.02000
6.618.714.112.32001
4.221.211.211.92002
15.113.017.213.92003
7.118.922.315.62004
7.527.511.514.22005
10.515.413.812.62006
Schizophrenia (ICD-10, codes F20-29)
3.916.015.211.61999
8.712.216.712.32000
7.316.615.011.62001
7.910.013.09.82002
9.915.214.811.92003
4.818.117.913.62004
8.213.119.313.82005
6.514.315.211.62006
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Table 6| Age and sex standardised mortality ratios for natural causes of death in year after hospital discharge between 1999 and 2006 by
age and principal diagnosis
65-84 years45-64 years<45 yearsAll agesYear of discharge
Bipolar disorder (ICD-10, code F31)
1.11.31.01.11999
1.11.51.41.12000
1.21.31.31.12001
1.51.72.01.42002
1.42.00.71.42003
1.31.82.31.22004
1.61.21.81.42005
1.61.80.31.42006
Schizophrenia (ICD-10, codes F20-29)
1.32.72.31.21999
1.63.02.61.52000
1.62.72.21.32001
1.52.92.91.52002
1.83.72.91.82003
1.72.82.71.62004
1.82.94.61.82005
1.83.22.71.72006
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Table 7| Age and sex standardisedmortality ratios for death in year after hospital discharge between 1999 and 2006 by principal psychiatric
diagnosis and specific cause of death
Suicide and undetermined intent¶Accidents§Respiratory disease‡Cancer†Circulatory disease*Year of discharge
Bipolar disorder (ICD-10, code F31)
13.56.83.00.41.61999
21.25.22.50.71.42000
24.84.73.70.51.62001
20.24.95.70.81.82002
27.74.05.00.91.82003
32.14.84.90.51.82004
29.55.04.60.62.12005
19.86.65.80.62.52006
Schizophrenia (ICD-10, codes F20-29)
19.56.53.10.81.61999
19.67.53.51.02.02000
21.85.84.00.91.62001
17.84.24.41.01.92002
23.35.35.31.12.52003
24.76.85.61.12.22004
24.08.36.01.12.42005
20.96.34.71.32.52006
*ICD-10: I00-I99; ICD-9: 390-459.
†ICD-10: C00-D48; ICD-9: 140-239.
‡ICD-10: J00-99; ICD-9: 460-519.
§ICD-10: V01-X59; ICD9: E800-E929.
¶ICD-10: X60-X84, Y10-Y34; ICD-9: E950-E959, E980-E989.
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Figures
Fig 1 Trend in standardised 365 day all cause mortality ratio for all people discharged from hospital with principal diagnosis
of bipolar disorder or schizophrenia
Fig 2 All cause mortality rate within 365 days after discharge per 1000 people discharged with principal diagnosis of bipolar
disorder by age
Fig 3 All cause mortality rate within 365 days after discharge per 1000 people discharged with principal diagnosis of
schizophrenia by age
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